1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (1694)
  2. Journal Article (1416)
  3. Review (80)
  4. Editorial (56)
  5. Book Section (35)
  6. Guidelines (24)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3351)
  2. Solid Tumor Oncology Division (3351)
  3. Thoracic Oncology (3351)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Human Oncology and Pathogenesis Program (625)

More Groups

People
  1. Mark Kris (869)
  2. Alexander Drilon (631)
  3. Gregory Riely (599)
  4. Charles Rudin (488)
  5. Marc Ladanyi (414)
  6. Matthew Hellmann (411)

More People

Years
  1. 2025 (73)
  2. 2024 (270)
  3. 2023 (272)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (692)
  2. Journal of Thoracic Oncology (513)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (156)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (769)
  2. Elsevier Inc. (734)
  3. American Association for Cancer Research (383)
  4. Oxford University Press (350)
  5. Nature Publishing Group (148)
  6. Elsevier Science, Inc. (78)

More Publishers

Results (3351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A rules-based algorithm to prioritize poor prognosis cancer patients in need of advance care planning
    Journal Article

    Bestvina, C. M.; Wroblewski, K. E.; Daly, B.; Beach, B.; Chow, S.; Hantel, A.; Malec, M.; Huber, M. T.; Polite, B. N.
    Journal of Palliative Medicine (2018)

    Fulltext@MSK | Save
  • CT features of HER2-mutant lung adenocarcinomas
    Journal Article

    Sawan, P.; Plodkowski, A. J.; Li, A. E.; Li, B. T.; Drilon, A.; Capanu, M.; Ginsberg, M. S.
    Clinical Imaging (2018)

    Fulltext@MSK | Save
  • Small-cell carcinomas of the bladder and lung are characterized by a convergent but distinct pathogenesis
    Journal Article

    Chang, M. T.; Penson, A.; Desai, N. B.; Socci, N. D.; Shen, R.; Seshan, V. E.; Kundra, R.; Abeshouse, A.; Viale, A.; Cha, E. K.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • RASA1 and NF1 are preferentially co-mutated and define a distinct genetic subset of smoking-associated non–small cell lung carcinomas sensitive to MEK inhibition
    Journal Article

    Hayashi, T.; Desmeules, P.; Smith, R. S.; Drilon, A.; Somwar, R.; Ladanyi, M.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Looking ahead to new therapies in small cell lung cancer
    Journal Article

    Rudin, C. M.
    Clinical Advances in Hematology & Oncology (2018)

    Fulltext@MSK | Save
  • Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers
    Journal Article

    Drilon, A.; Somwar, R.; Mangatt, B. P.; Edgren, H.; Desmeules, P.; Ruusulehto, A.; Smith, R. S.; Delasos, L.; Vojnic, M.; Plodkowski, A. J.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Modeling epithelial plasticity-induced erlotinib resistance in non-small cell lung cancer
    Meeting Abstract

    Wang, H.; Cades, J.; Yochum, Z.; Nugent, K.; Rudin, C.; Burns, T.; Tran, P.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Loss of Keap1 promotes KRAS-driven lung cancer and results in genotype-specific vulnerabilities
    Meeting Abstract

    Romero, R.; Sayin, V. I.; Shawn, D. M.; Bauer, M.; Singh, S. X.; LeBoeuf, S.; Karakousi, T. R.; Ellis, D. C.; Bhutkar, A.; Sanchez-Rivera, F.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Targeted therapy-induced senescence enhances immune surveillance of KRAS mutant lung cancers
    Meeting Abstract

    Ruscetti, M.; Leibold, J.; Bott, M. J.; Shields, M.; Chen, C. C.; Fennell, M.; Chen, H. C.; Baslan, T.; Salgado, N. R.; Manchado, E.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save